Eagles QB Jalen Hurts Out With Blood Clots

Philadelphia Eagles quarterback Jalen Hurts is facing a lengthy recovery and is likely out for the remainder of the 2026 NFL season after being diagnosed with blood clots, according to reports from NFL Network insiders Ian Rapoport and Adam Schefter.

The medical situation began when specialists initially diagnosed Hurts with a left calf superficial vein thrombosis while he was in London. However, subsequent testing and thorough medical monitoring revealed a more serious condition: a deep vein thrombosis (DVT) accompanied by bilateral pulmonary emboli—blood clots in the lungs.

In a joint statement released by the Philadelphia Eagles and team officials, medical experts provided transparency regarding the diagnosis and ongoing treatment plan. The organization emphasized that despite the severe nature of the condition, Hurts is currently clinically stable and experiences no significant functional limitations.

Treatment and Recovery Timeline

Medical specialists determined that Hurts’ treatment will focus exclusively on anticoagulation therapy, commonly known as blood thinners. Because of the necessary reliance on these medications, medical protocols strictly prohibit him from participating in any contact activities, including football practices and games.

The expected recovery timeline for the quarterback is approximately three months. This timeframe effectively places his return for the current NFL season in serious doubt.

Despite the setback to the Eagles’ roster, team physicians expressed optimism about his long-term health and athletic future. Officials noted that Hurts’ overall prognosis is very good and that a full recovery is anticipated.

Team Support and Outlook

The Eagles stated that once Hurts finishes his course of blood thinners and receives medical clearance, he will have the opportunity to resume contact football activities. Until then, he plans to remain actively engaged with the team, supporting his teammates from the sidelines and continuing his conditioning work under medical supervision.

Team leadership and medical experts reiterated their expectation that Hurts will suffer no long-term health effects from the condition, allowing him to resume his career fully once the recovery period concludes.